• Media Centre
  • Investor relations
  • Client area
  • Client area
  • Stewardship policy
  • Annual reports service

Form of Proxy

DEXCOM, INC.

Notes

No. Proposition For Against Abstain
1

Election of Director to hold office until our 2027 annual meeting of stockholders: Steven Altman

2

Election of Director to hold office until our 2027 annual meeting of stockholders: Dr. Euan Ashley

3

Election of Director to hold office until our 2027 annual meeting of stockholders: Nicholas Augustinos

4

Election of Director to hold office until our 2027 annual meeting of stockholders: Richard Collins

5

Election of Director to hold office until our 2027 annual meeting of stockholders: Rimma Driscoll

6

Election of Director to hold office until our 2027 annual meeting of stockholders: Mark Foletta

7

Election of Director to hold office until our 2027 annual meeting of stockholders: Renée Galá

8

Election of Director to hold office until our 2027 annual meeting of stockholders: Bridgette Heller

9

Election of Director to hold office until our 2027 annual meeting of stockholders: Jacob Leach

10

Election of Director to hold office until our 2027 annual meeting of stockholders: Kyle Malady

11

Election of Director to hold office until our 2027 annual meeting of stockholders: Rick Osterloh

12

Election of Director to hold office until our 2027 annual meeting of stockholders: Kevin Sayer

13

To ratify the selection by the Audit Committee of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026.

14

To provide a non-binding advisory vote on the compensation of our named executive officers for the fiscal year ended December 31, 2025.